Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Translational Sciences Intern will support the Translational Sciences team in advancing programs that connect preclinical discovery with clinical development. This role provides exposure to how Translational Research integrates molecular biology, pharmacology, biomarker discovery, and clinical data to inform therapeutic development in precision oncology. The intern will gain insight into how translational strategies are developed to understand drug mechanisms, identify biomarkers of response and resistance, and guide clinical trial design. This position is ideal for a student interested in translational cancer research and the interface between laboratory science and clinical application. The role focuses on learning, analysis, and cross-functional collaboration within a multidisciplinary drug development environment.
This role provides the opportunity to learn some or all the following, depending on project assignments and team needs.
How translational research supports the development of targeted therapies in oncology.
How biomarker strategies are developed to support clinical trials and precision medicine approaches. • How preclinical data are integrated with clinical observations to understand mechanisms of response and resistance.
How cross-functional teams across discovery biology, pharmacology, clinical development, and bioinformatics collaborate in drug development.
How experimental and clinical datasets are analyzed and interpreted to generate translational insights.
How translational scientists communicate complex scientific findings to multidisciplinary teams.
Required Skills, Experience and Education:
Strong analytical, critical-thinking, and problem-solving skills.
Ability to interpret scientific literature and synthesize complex scientific information.
Strong written and verbal communication skills.
Interest in oncology, molecular biology, or translational research.
Organized, detail-oriented, and able to work independently with guidance.
Professional curiosity and willingness to learn new concepts.
Pursuing a bachelor’s or master’s degree in a STEM field (e.g., biology, biochemistry, molecular biology, biomedical engineering, or related discipline).
Preferred Skills:
Coursework or research experience in cancer biology, molecular biology, or pharmacology.
Familiarity with biomarker concepts or translational research approaches.
Experience with basic laboratory techniques or biological data analysis.
Experience preparing scientific presentations or summarizing research findings.
Interest in precision medicine and targeted cancer therapies.
#LI-Hybrid #LI-AP1
The base pay salary range for this intern position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
What We Do
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses
